A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Multiple Myeloma
At a glance
- Phase
- Phase 4
- Study type
- Interventional
- Sponsor
- Janssen Research & Development, LLC
- Enrolment target
- 295
- Started
- 9 March 2022
- Main results due
- 29 July 2037
- Study sites
- 50
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Participants who have received at least one dose of cilta-cel in a Company-sponsored clinical study * Participants who have provided informed consent for this study
What this study is about
In the sponsor’s own words, from the registry.
The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.
Study sites(50)
Mayo Clinic Cancer Center-Scottsdale
Phoenix, Arizona, United States
Recruiting
City of Hope
Duarte, California, United States
Recruiting
University of California San Francisco
San Francisco, California, United States
Recruiting
Stanford University Medical Center
Stanford, California, United States
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
Recruiting
Emory University
Atlanta, Georgia, United States
Recruiting
Northwestern University
Chicago, Illinois, United States
Recruiting
University of Chicago
Chicago, Illinois, United States
Recruiting
Indiana University
Indianapolis, Indiana, United States
Recruiting
Kansas University Medical Center
Westwood, Kansas, United States
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Recruiting
Mayo Clinic Rochester
Rochester, Minnesota, United States
Recruiting
Washington University School Of Medicine
St Louis, Missouri, United States
Recruiting
Hackensack University Medical Center
Hackensack, New Jersey, United States
Recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Recruiting
Roswell Park Cancer Institute
Buffalo, New York, United States
Recruiting
Mount Sinai Medical Center
New York, New York, United States
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting
Montefiore Medical Center
The Bronx, New York, United States
Recruiting
Levine Cancer Institute
Charlotte, North Carolina, United States
Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Recruiting
Sarah Cannon Research Institute
Nashville, Tennessee, United States
Recruiting
MD Anderson Cancer Center
Houston, Texas, United States
Recruiting
Froedtert Memorial
Milwaukee, Wisconsin, United States
Recruiting
UZ Gent
Ghent, Belgium
Recruiting
UZ Leuven
Leuven, Belgium
Recruiting
Peking University Third Hospital
Beijing, China
Active, not recruiting
West China Hospital Si Chuan University
Chengdu, China
Active, not recruiting
Fujian Medical University Union Hospital
Fuzhou, China
Active, not recruiting
Sun Yat-sen University Cancer Hospital
Guangzhou, China
Active, not recruiting
First Hospital, Zhejiang University Medical College
Hangzhou, China
Active, not recruiting
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, China
Active, not recruiting
Jiangsu Province Hospital
Nanjing, China
Active, not recruiting
Shanghai Changzheng Hospital
Shanghai, China
Active, not recruiting
Ruijin Hospital Shanghai Jiao Tong University
Shanghai, China
Active, not recruiting
Shanghai Fourth People s Hospital
Shanghai, China
Active, not recruiting
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
Active, not recruiting
CHRU de Lille Hopital Claude Huriez
Nord, France
Recruiting
Hopital Saint Louis
Paris, France
Recruiting
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Recruiting
Nagoya City University Hospital
Nagoya, Japan
Active, not recruiting
Japanese Red Cross Medical Center
Shibuya City, Japan
Active, not recruiting
VU Medisch Centrum
Amsterdam, Netherlands
Recruiting
University Medical Center Groningen
Groningen, Netherlands
Recruiting
Clinica Univ. de Navarra
Pamplona, Spain
Recruiting
Hosp Clinico Univ de Salamanca
Salamanca, Spain
Recruiting
Showing 50 of 50 sites. 37 of the 50 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT05201781. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me